Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-14

Clinical Trial Update: Coenzyme Q10 in Relation of the Lipid Peroxidation, Antioxidant Enzyme Activities in Coronary Artery Disease Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluated Coenzyme Q10 in patients with coronary artery disease, examining its effects on lipid peroxidation and antioxidant enzyme …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED